Prospects for diagnosis of prostate cancer by biomarkers in the urine.

Dual pathways for nuclear factor kappaB activation by angiotensin II in vascular smooth muscle: phosphorylation of p65 by IkappaB kinase and ribosomal kinase.

Effect of thymosin beta15 on the branching of developing neurons.

Use of thymosin beta15 as a urinary biomarker in human prostate cancer.

Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells.

Synthesis and angiogenetic activity in the chick chorioallantoic membrane model of thymosin beta-15.

Molecular cloning and structural characterization of the rat thymosin beta15 gene.

Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study.

C-terminal variations in beta-thymosin family members specify functional differences in actin-binding properties.

Thymosin beta15 expression in tumor cell lines with varying metastatic potential.